NCT05306808

Brief Summary

The study recruits breast cancer survivors who are already on chemotherapy or are going to start chemotherapy. Subjects will be asked for their preference to attend physiotherapy and educational class (for intervention group) or decline for it (for control group). For intervention group, subject will attend 24 sessions of physiotherapy (exercise class) and 10 sessions of educational class over 12 weeks. The supervised 1-hour group exercise class will be conducted twice a week. Educational class will be once a week, with topics covering physical activity, management of fatigue, lymphoedema, neuropathy, brain fog, return to work, stress, nutrition, sexuality, psychosocial and caregiver issues. Subjects in control group will be asked to exercise on their own in the 12 weeks. 12 weeks later, all subjects will attend a 2-hour survivorship transitional class, with topics covering cancer surveillance and follow up, addressing fear of recurrence: symptom and support, neuropathy/ fatigue/physical impairment/ brain fog, physical activity and diet, screening for colorectal and cervical cancers, return to work and community resources. During the class, a screening questionnaire will be administered to identify further physical, rehabilitation and psychosocial needs and to triage these patients to relevant hospital and community services. Outcome assessment will be done at pre-intervention, after intervention, 6 months and 1 year after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2019

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2021

Completed
10 months until next milestone

First Posted

Study publicly available on registry

April 1, 2022

Completed
Last Updated

November 2, 2022

Status Verified

October 1, 2021

Enrollment Period

2.6 years

First QC Date

June 7, 2021

Last Update Submit

October 31, 2022

Conditions

Outcome Measures

Primary Outcomes (12)

  • 6 minute walk test

    distance covered in 6 minutes with comfortable walking speed

    Week0

  • 6 minute walk test

    distance covered in 6 minutes with comfortable walking speed

    Week12

  • 6 minute walk test

    distance covered in 6 minutes with comfortable walking speed

    Month6

  • Frenchay Activities Index (FAI)

    measure of engagement in instrumental activities of daily living. The scale provides a summed score from 15-60. Higher FAI score indicates higher instrumental activities

    Week0

  • Frenchay Activities Index (FAI)

    measure of engagement in instrumental activities of daily living. The scale provides a summed score from 15-60. Higher FAI score indicates higher instrumental activities

    Week12

  • Frenchay Activities Index (FAI)

    measure of engagement in instrumental activities of daily living. The scale provides a summed score from 15-60. Higher FAI score indicates higher instrumental activities

    Month6

  • Functional Assessment of Cancer Therapy scale (FACT)-fatigue

    Fatigue scale, All items are summed to create a single fatigue score with a range from 0 to 52. Higher score indicates better outcome.

    Week0

  • Functional Assessment of Cancer Therapy scale (FACT)-fatigue

    Fatigue scale, All items are summed to create a single fatigue score with a range from 0 to 52. Higher score indicates better outcome.

    Week12

  • Functional Assessment of Cancer Therapy scale (FACT)-fatigue

    Fatigue scale, All items are summed to create a single fatigue score with a range from 0 to 52. Higher score indicates better outcome.

    Month6

  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)

    Measurement on quality of life. All of the scales and single-item measures range in score from 0 to 100. A high score for a functional scale represents a high level of functioning, whereas a high score for a symptom scale/single item represents a high level of symptom.

    Week0

  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)

    Measurement on quality of life. All of the scales and single-item measures range in score from 0 to 100. A high score for a functional scale represents a high level of functioning, whereas a high score for a symptom scale/single item represents a high level of symptom.

    Week12

  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)

    Measurement on quality of life. All of the scales and single-item measures range in score from 0 to 100. A high score for a functional scale represents a high level of functioning, whereas a high score for a symptom scale/single item represents a high level of symptom.

    Month6

Secondary Outcomes (3)

  • International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Week0

  • International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Week12

  • International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Month6

Study Arms (2)

center-based exercise

EXPERIMENTAL

Participants in intervention group will attend a program combining 24 sessions of physiotherapy and 10 sessions of educational class over 12 weeks.

Other: physiotherapy class

exercise on his/her own

NO INTERVENTION

Participants in control group will be asked to exercise on their own, they will only attend 10 sessions of educational class over 12 weeks.

Interventions

The supervised 1-hour group exercise class will be conducted twice a week, with a maximum of 8 patients in each class. Subjects will be given a home log for exercise recording. If subjects are unable to attend exercise class for any reason (eg., low counts or feeling unwell, etc.), they will be advised to continue xercises at home. On the day of one of the exercise classes each week, there will be an additional 1-hour group education/ discussion session which may be conducted by PT, OT, APN, dietician or medical social worker. Topics covered will include physical activity, management of fatigue, lymphoedema, neuropathy, brain fog, return to work, stress, nutrition, sexuality, psychosocial and caregiver issues. There will be 10 sessions of educational class in total for each subject.

center-based exercise

Eligibility Criteria

Age21 Years - 80 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly females will be recruited
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females between 21 - 80 years old;
  • Breast cancer patients before or already on the treatment of chemotherapy, targeted therapy, and/or radiotherapy;
  • Be able to provide consent and complete questionnaires;
  • Be able to walk independently in the community without use of gait aids.
  • Breast cancer patients who are suitable for exercise.

You may not qualify if:

  • Pregnant;
  • Uncontrolled hypertension (Resting BP \>160/90 mm Hg), or history of recurring or persistent hypotension in the past 2 months;
  • History of recent myocardial infarction or unstable angina (within the past 6 months);
  • Significant valvular disease i.e. severe aortic stenosis and moderate-severe mitral regurgitation;
  • Patient with end stage organ disease (e.g. ESRF, end stage COPD);
  • Tumor infiltration of axial or weight-bearing bones with risk of pathological fractures or compression of the spinal cord;
  • Patient with recent stroke within the past 6 months;
  • With other neuromusculoskeletal disorders such as osteoarthritis of such severity as to limit ability to participate in group exercise classes;
  • Already participating in regular physical activity (150min of moderate or 75min of vigorous physical activity/week);
  • Deemed inappropriate by primary oncologists.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Univerity Hospital

Singapore, Singapore

Location

Related Publications (1)

  • Chandran G, Tang N, Ngo ELP, Huang S, Tong SI, Ong JX, Chew E. Comparing the efficacy of a multi-dimensional breast cancer rehabilitation programme versus a home-based exercise programme during adjuvant cancer treatment. BMC Cancer. 2024 Mar 21;24(1):361. doi: 10.1186/s12885-024-12080-5.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Effie Chew

    National University Hospital, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants in the intervention group will attend a program combing 24 sessions of physiotherapy and 10 sessions of educational class over 12 weeks. Participants in the control group will be asked to exercise on their own.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2021

First Posted

April 1, 2022

Study Start

March 17, 2017

Primary Completion

October 21, 2019

Study Completion

October 21, 2019

Last Updated

November 2, 2022

Record last verified: 2021-10

Locations